Welcome to LookChem.com Sign In|Join Free

CAS

  • or

939758-75-5

Post Buying Request

939758-75-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

939758-75-5 Usage

General Description

7-Fluoro-1,2,3,4-tetrahydroquinoline is a chemical compound with the molecular formula C9H10FN. It is a fluorinated derivative of tetrahydroquinoline, which is a heterocyclic compound commonly found in various natural products and pharmaceutical drugs. 7-Fluoro-1,2,3,4-tetrahydroquinoline has potential applications in medicinal chemistry and drug development due to its structural features and biological activities. Its fluorinated moiety can enhance the compound's pharmacokinetic properties and increase its binding affinity to target proteins, making it a valuable scaffold for the design of new drug candidates. Additionally, the presence of the fluorine atom can also introduce unique chemical reactivity and selectivity, expanding the compound's synthetic and pharmaceutical potential. Overall, 7-Fluoro-1,2,3,4-tetrahydroquinoline is a promising chemical entity with important implications for drug discovery and development.

Check Digit Verification of cas no

The CAS Registry Mumber 939758-75-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,7,5 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 939758-75:
(8*9)+(7*3)+(6*9)+(5*7)+(4*5)+(3*8)+(2*7)+(1*5)=245
245 % 10 = 5
So 939758-75-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H10FN/c10-8-4-3-7-2-1-5-11-9(7)6-8/h3-4,6,11H,1-2,5H2

939758-75-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Fluoro-1,2,3,4-tetrahydroquinoline

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:939758-75-5 SDS

939758-75-5Downstream Products

939758-75-5Relevant articles and documents

Dehydrogenative and Redox-Neutral N-Heterocyclization of Aminoalcohols Catalyzed by Manganese Pincer Complexes

Brzozowska, Aleksandra,Rueping, Magnus,Sklyaruk, Jan,Zubar, Viktoriia

supporting information, (2022/03/17)

A new manganese catalyzed heterocyclization of aminoalcohols has been accomplished. A wide range of heterocycles were synthesized, including 1,2,3,4-tetrahydroquinolines, dihydroquinolinones, and 2,3,4,5-tetrahydro-1H-benzo[b]azepines. The reaction is performed under mild reaction conditions using air and moisture stable manganese catalysts. The desired heterocycles were obtained in good to excellent yields.

DIACYLGLYCEROL KINASE MODULATING COMPOUNDS

-

Paragraph 1465; 1467, (2021/07/02)

The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.

4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS

-

Page/Page column 274, (2016/06/14)

The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 939758-75-5